pharmacopeia

Sleep Apnoea Syndrome

also: Sleep Apnea Syndrome

6 drugs3,992 FAERS reportsMedDRA PT
GET
/api/v1/reaction/sleep-apnoea-syndrome
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D012891

Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.

Source: U.S. National Library of Medicine — MeSH (Sleep Apnea Syndromes)

Drugs reporting Sleep Apnoea Syndrome (6)

Share = reports listing this reaction ÷ total matched reports for the drug. means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Protriptyline88.3%
  2. 2Clocortolone28.0%
  3. 3Pramlintide54.9%
  4. 4Oxybate2,5793.9%
  5. 5Armodafinil6253.0%
  6. 6Modafinil7732.4%

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Sleep Apnea Syndromes as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients